Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)

Journal of Clinical Lipidology · Published 2026-07-01 · DOI 10.1016/j.jacl.2026.07.028

Free full text

Authors (5)

Dirk J. Blom, Dominique Larrey, Lukas Makris, James Underberg, Sallyann O’Brien

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Blom, D., Larrey, D., Makris, L., et al. (2026). Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry (LOWER). Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2026.07.028

Related articles